Neogen Chemicals: Update on Insurance Claims
Neogen Chemicals (NEOGEN) filed a disclosure titled "Update on Insurance Claims". The company is valued at about ₹6,218 crore.
What happened
Neogen Chemicals (NEOGEN) filed a disclosure with the exchanges on 30 October 2026 at 01:44 PM titled "Update on Insurance Claims".
Company snapshot
Neogen Chemicals is a small-cap company in the Chemicals sector, with a market value of about ₹6,218 crore.
The stock last traded at ₹2,270.9, against a 52-week range of ₹966.7–₹2,785 (18.5% below the high).
Before this filing the shares had moved −4.8% over the month and +10.9% over three months. Average daily turnover over the last 20 sessions was about ₹50.06 crore.
Promoters held 53.01% at the end of Q2 FY27; 23.00% of promoter shares were pledged. Foreign institutions owned 3.87% and domestic institutions 17.08%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 187 | 10.3 | 3.89 |
| Q2 FY26 | 209 | 3.4 | 1.28 |
| Q3 FY26 | 220 | 3.7 | 1.4 |
| Q4 FY26 | 247 | 11.4 | 4.32 |
| Q1 FY27 | 250 | 17.1 | 6.29 |
What history shows
This is not the company's first regulatory disclosure: BCEIE has 3 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 2.0% on average the next trading day and was up 5.6% on average after five days (3 filings with price data).
Across 128 similar disclosures by other Chemicals companies, shares moved +0.5% on average the next day and +1.2% over five days; 52% of them rose the next day.
Market-wide, 5,549 regulatory filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 6 Sept 2026 | Regulatory | +3.5% | +11.0% |
| 6 Sept 2026 | Receipt of show cause cum demand notice from the Office of the… | +3.5% | +11.0% |
| 17 Jul 2026 | Regulatory | −0.9% | −5.1% |
What to watch
- 31 October 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.